🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/11/2015 5,46 5,88 5,43 5,75 +5,50% 8,24% 1.614.000
10/11/2015 5,42 5,48 5,28 5,45 +0,55% 3,69% 836.300
09/11/2015 5,32 5,46 5,27 5,42 +1,31% 3,57% 755.600
06/11/2015 5,29 5,37 5,16 5,35 +0,75% 3,97% 874.900
05/11/2015 5,44 5,52 5,23 5,31 -2,93% 5,33% 837.200
04/11/2015 5,34 5,54 5,27 5,47 +3,01% 5,06% 930.900
03/11/2015 5,37 5,40 5,20 5,31 -0,75% 3,63% 975.600
02/11/2015 5,17 5,45 5,12 5,35 +3,88% 6,38% 842.600
30/10/2015 5,23 5,29 5,12 5,15 -0,77% 3,25% 641.200
29/10/2015 5,19 5,40 5,09 5,19 +0,39% 5,97% 1.053.900
28/10/2015 5,27 5,34 5,10 5,17 -1,34% 4,52% 1.056.800
27/10/2015 5,13 5,29 5,11 5,24 +0,96% 3,51% 1.236.100
26/10/2015 5,38 5,43 5,15 5,19 -2,99% 5,20% 835.800
23/10/2015 5,01 5,36 4,93 5,35 +7,86% 8,58% 1.513.100
22/10/2015 4,97 5,04 4,83 4,96 +1,22% 4,23% 1.130.900
21/10/2015 5,20 5,26 4,83 4,90 -5,59% 8,27% 1.726.600
20/10/2015 5,18 5,32 5,10 5,19 -1,14% 4,25% 1.162.000
19/10/2015 5,33 5,56 5,14 5,25 -2,42% 7,88% 1.512.100
16/10/2015 5,52 5,62 5,34 5,38 -2,18% 5,11% 1.274.100
15/10/2015 5,20 5,55 5,20 5,50 +5,16% 6,73% 1.048.900
14/10/2015 5,26 5,47 5,12 5,23 -0,57% 6,62% 1.443.600
13/10/2015 5,60 5,67 5,11 5,26 -5,57% 10,00% 2.074.500
12/10/2015 5,85 5,89 5,53 5,57 -5,43% 6,15% 966.500
09/10/2015 5,72 5,97 5,65 5,89 +2,26% 5,63% 954.600
08/10/2015 5,70 5,79 5,49 5,76 +1,23% 5,26% 1.130.500
07/10/2015 5,97 6,02 5,64 5,69 -3,89% 6,40% 1.890.800
06/10/2015 6,15 6,23 5,80 5,92 -4,52% 6,99% 1.451.600
05/10/2015 5,99 6,24 5,92 6,20 +6,90% 5,34% 1.735.300
02/10/2015 5,34 5,91 5,30 5,80 +2,84% 11,42% 2.254.700
01/10/2015 5,91 5,96 5,51 5,64 -2,08% 7,61% 1.925.500